MedTrace Logo

Effects of Repeated Doses of Foliglurax on Drug Metabolizing Enzymes in Healthy Subjects

NCT04275115 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-04-24

No results posted yet for this study

Summary

The purpose of this study is to help determine which types of drugs that may interact with foliglurax

Conditions

  • Healthy

Interventions

DRUG

Drug Cocktail

Single oral dose of the cocktail probe substrates (caffeine 200 mg, montelukast 10 mg, midazolam 4 mg)

DRUG

Foliglurax

Foliglurax

DRUG

midazolam iv

Single intravenous (iv) dose of midazolam 0.025 mg/kg

Sponsors & Collaborators

  • H. Lundbeck A/S

    lead INDUSTRY

Principal Investigators

Study Design

Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-10
Primary Completion
2020-04-03
Completion
2020-04-03

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04275115 on ClinicalTrials.gov